SESSION SUMMARIES

June 11, 2024

Roadmap for the Main Symposium Day: Importance of Sessions and Speakers.  Keynote talks and morning panels: Why are they important?; Session Track Options; Q&A session

  • Mary Beth Thomas, Ph.D., Senior Vice President, Science and Business Development
  • Scott Dorney, Executive Director, North Carolina Military Business Center

Ecosystem Partners and How They Can Help You

  • Speakers TBA

Federal Funding Vehicles

  • Speakers TBA

June 12, 2024

Enabling the Warfighter: Operational Requirements for Tactical Medicine. The Fort Liberty Research Institute, a program of The Geneva Foundation, is honored to lead a panel that will present the needs, gaps and opportunities for industry and innovators to support the medical requirements of America’s premier warfighting commands.

  • Moderator: Lieutenant Colonel (Ret.) Stephen DeLellis, Senior Technical Advisor, The Geneva Foundation
  • Sergeant Major Rich Ciuk, Senior Enlisted Medical Advisor, US Army Special Operations Command
  • Sergeant Major Tinamarie Reese, Senior Enlisted Medical Advisor, US Army Reserve Command
  • Sergeant Major Tony Stephens, Senior Enlisted Medical Advisor, Joint Medical Unit
  • Sergeant Major Matt Garrison, Senior Enlisted Medical Advisor, 3rd Operational Support Group
  • Marine Corps Special Operations Command (invited)

Sustaining the Medical Treatment Facilities: Logistics, Acquisition and R&D.  Command representatives from the Defense Health Agency (DHA) and constituent military medical treatment facilities (MTFs) will describe the requirements and acquisition processes to logistically sustain military MTFs nationwide.  They will also highlight resources and opportunities for joint research between academia, industry and military investigators from DHA and MTFs in North Carolina.

  • Moderator and Speaker: Colonel David Zinnante, Commander/Director, Womack Army Medical Center
  • Colonel Bruce Argueta, Medical Director, Defense Logistics Agency, Medical
  • Commander Kibwe Hampden, Defense Health Agency-Atlantic

Breakthrough Technologies: Opportunities in Military Medicine and Biosecurity. At a time when innovative technologies in the life sciences are advancing at incredible pace, the opportunity to create groundbreaking solutions to heal and protect our military and the US population is greater than ever. While many technical and regulatory challenges remain, understanding what these innovations represent and how transformational they could be is critical in advancing them towards a future marketplace. This panel of speakers will describe the work their labs or companies are pursuing to address complex medical or health security challenges that impact our military and civilian health care markets – with the hope of inspiring with their potential solutions.

  • Ronald K. Hann, Jr., Ph.D., Director, Technology Integration, Wake Forest Institute for Regenerative Medicine
  • Rodolphe Barrangou, Ph.D., Todd R. Klaenhammer Distinguished Professor, Department of Food, Bioprocessing and Nutrition Sciences, North Carolina State University
  • Rob Kirkton, Ph.D., Director, New Product Development, Humacyte
  • Seema Nandi, Ph.D., Co-Founder and Chief Executive Officer, SelSym Biotech, Inc.

Department of Veterans Affairs One-on-One Meetings. The Department of Veterans Affairs, in collaboration with the NCMBC, will host one-on-one meetings with industry at MBB 2024. This forum provides a unique opportunity for dialogue with key decision makers from multiple VA offices.  Participants should bring capabilities statements and prepare a concise “elevator pitch” to communicate a compelling business case for the VA to procure their goods and/or services.

  • Marri "Nicki" Frayer, MBA, MHA, BSN, NE-BC, VHA-CM, Executive Director/CEO, Fayetteville NC VA Coastal Health Care System
  • Jonathan Benoit, Deputy Network Director, VISN 6, Department of Veterans Affairs
  • Asheville VAMC (invited)
  • Durham VAMC (invited)
  • Salisbury VAMC (invited)
  • Department of Veterans Affairs, VISN 7 (invited)
  • Department of Veterans Affairs, OSDBU (invited)

Medical Challenges in Large-Scale Combat Operations. This panel will address innovative medical support required in contested combat environments, focusing on autonomous resupply and casualty evacuation to enhance forward unit capabilities.  Methodologies will incorporate a counter-EW posture to protect medical logistics from adversarial threats, emphasizing resilience in contested environments. This approach underlines strategic advancements in military medical logistics, ensuring operational effectiveness and readiness in complex combat scenarios.

  • Colonel Jonathan Catalano, Medical Capability Developer, Medical Capability Development Integration Directorate, Futures and Concepts Center, US Army Futures Command
  • Womack Army Medical Center (invited)
  • Army Applications Laboratory, Army Futures Command (invited)

Sustaining the Warfighter: Operational Medical Logistics, Acquisition and R&D.  Command representatives from Defense and major military commands will describe the requirements, acquisition and distribution processes to logistically sustain military medical units and warfighters worldwide.  They will also highlight ongoing programs, opportunities and vehicles for joint research with academia and industry to medically sustain the warfighter in future conflicts. 

  • Colonel Bruce Argueta, Medical Director, Defense Logistics Agency, Medical
  • US Army Medical Material Agency (invited)
  • US Army Medical Materiel Development Activity (invited)
  • Air Force Medical Logistics Operations Center (invited)
  • II Marine Expeditionary Force, 2nd Medical Battalion (invited)
  • 44th Medical Brigade, Fort Liberty (invited)

Funding the Next Generation of Medical, Biomedical and Health Security Solutions – An Investor’s Take. Many biomedical and health security innovations find support through traditional government support mechanisms – BAAs, SBIRs, STTRs, even OTAs. But most of these technologies will need much more capital than can be accessed through government sources.  When interests and objectives align, institutional investors can fund technology development, scale up, and commercialization working alongside DoD partners to support true dual-use technologies. This diverse panel of venture capital and public-private partnership investors will describe initiatives that support this technology development space, seeking to accelerate and scale private investment for national security.

  • Speakers TBA

 

56 days
left to
Medical, Biomedical & Biodefense: Support to the Warfighter Symposium